Short answer

No cannabis product is FDA-approved for hand arthritis. Evidence for pain relief is limited and mixed. Guidelines place topical NSAIDs, exercise, and oral NSAIDs first. Cannabis may help some people with pain, but trials in hand arthritis are small and short.

more on this topic

What hand arthritis is

Two types affect the hands.

read more

Both cause pain and loss of grip. Both last for years. A treatment is judged on long-term function, not one good day.

marijuana therapy for arthritis inflammation

What the evidence says

The 2017 National Academies review found conclusive evidence that cannabis treats chronic pain in adults. That review did not run arthritis-specific trials.

medical cannabis vs nsaids for arthritis

Lab data gives a reason to look. THC and CBD bind CB2 receptors, which sit on immune cells. CB2 activation reduces inflammatory signals in cell and animal models. A mechanism is not proof of benefit in human hands.

Reviews of rheumatic disease reach the same point: evidence for OA and RA is insufficient. Most studies use 10 to 60 patients, run 4 to 12 weeks, and lack a placebo group. Patient surveys report less pain and better sleep. Surveys cannot separate drug effect from expectation.

Evidence by condition:

Forms and onset times

Labels list THC and CBD in milligrams. A 10 mg CBD edible and a 10 mg CBD oil may act the same. A 1:1 product pairs equal THC and CBD. THC drives the psychoactive effect.

Dosing

No standard dose exists for arthritis. Pain trials used THC-dominant or 1:1 THC and CBD products.

  1. Start with 1 to 2.5 mg THC or 5 to 10 mg CBD.
  2. Wait 2 hours for oral products.
  3. Raise the dose by 1 to 2.5 mg every 2 to 3 days.
  4. Stop if side effects appear.

Keep a log of dose, time, and pain score. Hand function tests, such as grip strength or a 9-hole peg test, give better data than a single rating.

Risks and interactions

THC causes dizziness, dry mouth, memory problems, poor coordination, anxiety, and a faster heart rate. The National Academies put the risk of cannabis use disorder at about 9% of users. Smoking raises the risk of chronic bronchitis.

CBD at high doses can injure the liver. Epidiolex trials used up to 20 mg per kg per day and tracked liver enzymes. CBD blocks the CYP3A4 and CYP2C19 enzymes. That raises blood levels of some drugs.

Check these with a pharmacist before use:

Do not stop a prescribed arthritis drug to try cannabis. Methotrexate and biologics slow joint damage in RA. Cannabis does not.

Legal status in the US

FDA has approved three cannabis-related drugs: Epidiolex (CBD) for seizures, dronabinol, and nabilone. None is approved for arthritis. Hemp CBD with less than 0.3% THC is legal under the 2018 Farm Bill. Medical cannabis programs operate in 38 states and the District of Columbia as of 2024. Federal law still lists cannabis as Schedule I. State rules govern purchase, possession, and limits.

Questions for a clinician

  1. Will cannabis interact with my current drugs?
  2. Do I need a liver enzyme test?
  3. Is a topical a safer first step?
  4. What dose and product form do you suggest?
  5. What results count as improvement in 8 weeks?